Search Results

R3_2017-e_MSF No-cost extension

News | 26 October 2018
GENEVA – Unitaid is working with partners and stakeholders to explore introduction of long -acting (LA) technologies – such as injectable drugs, patches and implants – to treat infectious diseases...

News | 07 December 2018
...the latest health innovations requires operational, regulatory and administrative hurdles to be overcome. Long-acting products could be made available as long-acting injectables, implants, rings, patches, and weekly capsules. “A rich...

News | 20 April 2023
...which is native to South Asia and the Arabian Peninsula, has been detected in a growing number of African countries and is resistant to many insecticides in current use. Scientists...

...In the Foreign Ministry headquarters in Brasilia, she has worked as an Assistant to the Director General of the Trade Promotion Department and to the Undersecretary General for Africa, Asia,...

...South Asia, the Balkans, Afghanistan, Central Asia, Africa, UK & USA. Ganesh holds a Executive Masters in Innovation & Entrepreneurship from HEC, Paris, and a postgraduate degree in business administration....

News | 19 January 2016
...to have Hepatitis C. This includes many people in Africa, Central and East Asia. “Making daclatasvir widely available in Africa and Asia is important to simplify diagnosis and treatments, as...

News | 01 August 2022
...countries now have two cost-effective options – 3HP at $14.25 and 1HP at below $20 per course – to save the lives of their populations and prevent this disease.” Efforts...

News | 24 March 2018
...deaths and 100 percent protection for families from catastrophic TB-related costs by the year 2035. Unitaid’s active TB portfolio provides nearly US$ 180 million for developing innovative drugs, diagnostics and...

News | 01 July 2019
Geneva – ALIMA, PATH and Unitaid today announced a US$ 43 million initiative to put affordable, easy-to-use diagnostic devices into the hands of frontline health workers in Asia and Africa...